Unravelling druggable signalling networks that control F508del-CFTR proteostasis.
Ontology highlight
ABSTRACT: Cystic fibrosis (CF) is caused by mutations in CF transmembrane conductance regulator (CFTR). The most frequent mutation (F508del-CFTR) results in altered proteostasis, that is, in the misfolding and intracellular degradation of the protein. The F508del-CFTR proteostasis machinery and its homeostatic regulation are well studied, while the question whether 'classical' signalling pathways and phosphorylation cascades might control proteostasis remains barely explored. Here, we have unravelled signalling cascades acting selectively on the F508del-CFTR folding-trafficking defects by analysing the mechanisms of action of F508del-CFTR proteostasis regulator drugs through an approach based on transcriptional profiling followed by deconvolution of their gene signatures. Targeting multiple componen
SUBMITTER: Hegde RN
PROVIDER: S-EPMC4749566 | biostudies-literature | 2015 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA